We are live on ! Find out more
GC

Gruss & Co Portfolio holdings

AUM $40.8M
1-Year Est. Return 44%
This Fund
S&P 500
This Quarter Est. Return
+8.41%
1 Year Est. Return
+44%
3 Year Est. Return
+163.42%
5 Year Est. Return
+293.19%
10 Year Est. Return
+1,130.69%
AUM
$16.2M
AUM Growth
+$4.57M
Cap. Flow
+$4.24M
Cap. Flow %
26.21%
Top 10 Hldgs %
81.44%
Holding
23
New
9
Increased
2
Reduced
6
Closed
1

Top Buys

Rank Stock Value
1
NE icon
Noble Corp
NE
+$1.51M
2
MRNA icon
Moderna
MRNA
+$818K
3
NVDA icon
NVIDIA
NVDA
+$733K
4
CVX icon
Chevron
CVX
+$436K
5
GLD icon
SPDR Gold Trust
GLD
+$403K

Top Sells

Rank Stock Value
1
ABCL icon
AbCellera Biologics
ABCL
+$614K
2
TR icon
Tootsie Roll Industries
TR
+$405K
3
BSM icon
Black Stone Minerals
BSM
+$219K
4
MSFT icon
Microsoft
MSFT
+$28.8K
5
BX icon
Blackstone
BX
+$25.9K

Sector Composition

Rank Sector Weight
1 Energy 24.83%
2 Miscellaneous 22.71%
3 Healthcare 21.53%
4 Technology 10.11%
5 Real Estate 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABCL icon
1
AbCellera Biologics
ABCL
$3.7B
$2.59M 15.98%
255,400
-53,170
-17% -$614K
TBT icon
2
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$300M
$1.87M 11.54%
57,500
– –
NE icon
3
Noble Corp
NE
$7.44B
$1.6M 9.9%
+42,500
New +$1.51M
BXMT icon
4
Blackstone Mortgage Trust
BXMT
$2.39B
$1.52M 9.4%
71,860
-750
-1% -$17.8K
BSM icon
5
Black Stone Minerals
BSM
$3.12B
$1.42M 8.8%
84,463
-12,400
-13% -$219K
GLD icon
6
SPDR Gold Trust
GLD
$149B
$1.27M 7.86%
7,500
+2,500
+50% +$403K
MRNA icon
7
Moderna
MRNA
$58.1B
$898K 5.55%
+5,000
New +$818K
EOSE icon
8
Eos Energy Enterprises
EOSE
$1.41B
$732K 4.52%
494,605
+294,605
+147% +$382K
NVDA icon
9
NVIDIA
NVDA
$5.56T
$731K 4.51%
+50,000
New +$733K
AAPL icon
10
Apple
AAPL
$4.67T
$546K 3.37%
4,200
-100
-2% -$14.3K
IHF icon
11
iShares US Healthcare Providers ETF
IHF
$1.24B
$535K 3.31%
10,000
– –
CVX icon
12
Chevron
CVX
$409B
$449K 2.77%
+2,500
New +$436K
MSFT icon
13
Microsoft
MSFT
$3.71T
$360K 2.22%
1,500
-120
-7% -$28.8K
XOM icon
14
ExxonMobil
XOM
$656B
$276K 1.7%
+2,500
New +$268K
SLB icon
15
SLB Ltd
SLB
$85.3B
$267K 1.65%
+5,000
New +$249K
BX icon
16
Blackstone
BX
$102B
$245K 1.51%
3,300
-300
-8% -$25.9K
EVGO icon
17
EVgo
EVGO
$214M
$224K 1.38%
+50,000
New +$323K
DIS icon
18
Walt Disney
DIS
$182B
$217K 1.34%
+2,500
New +$239K
SBCF icon
19
Seacoast Banking Corp of Florida
SBCF
$3.35B
$203K 1.26%
+6,500
New +$207K
SA
20
Seabridge Gold
SA
$3.43B
$126K 0.78%
10,000
– –
PTON icon
21
Peloton Interactive
PTON
$2.37B
$85.8K 0.53%
10,800
– –
FIRY
22
Firy Inc
FIRY
$166M
$18.2K 0.11%
1,794
– –
TR icon
23
Tootsie Roll Industries
TR
$2.91B
– –
-13,709
Closed -$405K

Similar funds

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
FC
Fiduciary Counselling Saint Paul, Minnesota $40.6M AUM 9.32% 1-Year Est. Return
CIC
Cincinnati Indemnity Company Fairfield, Ohio $41.1M AUM 6.63% 1-Year Est. Return
CPM
Crescent Park Management East Palo Alto, California $40.5M AUM 5.55% 1-Year Est. Return
AP
Atairos Partners Bryn Mawr, Pennsylvania $41.1M AUM 4.36% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $41.5M AUM 245.82% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Gruss & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Gruss & Co held 23 positions worth $16.2M, up 39% from $11.6M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Gruss & Co deployed $4.24M of net new capital in Q4 2022, opening 9 new positions and adding to 2 existing holdings. Its largest new stake was Noble Corp: 42,500 shares worth $1.6M.

By sector, the portfolio is most concentrated in Energy at 25% of assets, up from 13% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was AbCellera Biologics, an estimated $614K trimmed.

  • Gruss & Co's largest Q4 2022 buy was Noble Corp: 42,500 shares worth $1.6M.
  • Gruss & Co added most to SPDR Gold Trust in Q4 2022, an estimated $403K increase.
  • Gruss & Co's biggest Q4 2022 reduction was AbCellera Biologics, cutting an estimated $614K.
  • Gruss & Co fully exited Tootsie Roll Industries in Q4 2022, selling an estimated $405K.
  • Gruss & Co's ten largest holdings make up 81% of its $16.2M portfolio in Q4 2022.
  • Gruss & Co opened 9 new positions and closed 1 in Q4 2022.
  • Gruss & Co's portfolio value rose 39% quarter-over-quarter to $16.2M.

Based on Gruss & Co's 13F filing for Q4 2022, filed 10 Feb 2023.